Using revenue model with the average price-to-sale ratio of 3.35...

Using revenue model with the average price-to-sale ratio of 3.35 for firms in healthcare product industry.
(reference: http://pages.stern.nyu.edu/~adamodar/New_Home_Page/datafile/psdata.html )

The current revenue for 2015 is $33millions, with growth over 10 percent on the basis of half-year result.
The market cap from the revenue model is about $115.5 millions, => share price about $0.69


The potential for CMP is much larger, due to massive investment into R&D and eHealth.
eHealth has already secured $10millions dollar order in China.
The initial revenue once eHealth launched, already exceeded 40millions. With improving margin and weak AUD.

If CMP can grow 10% in revenue each year. In 2020, revenue is about 64millions. => market cap of $214millions (SP of $1.2)

If CMP can grow 20% in revenue each year. In 2020, revenue is about 100millions => market cap of $335 millions.(SP of $2)